Anja Kahl
About Anja Kahl
Anja Kahl is the Clinical Trial Lead for Eliquis at Bristol-Myers Squibb, with a background in neuroscience and extensive clinical internship experience across various institutions globally.
Current Role at Bristol-Myers Squibb
Anja Kahl is currently serving as the Clinical Trial Lead for Eliquis at Bristol-Myers Squibb in Princeton, New Jersey. Since December 2017, her role involves leading clinical trials, overseeing the development process, and ensuring compliance with regulatory standards and protocols.
Previous Experience at Weill Cornell Medical College
Anja Kahl worked as a Postdoctoral Fellow in Neuroscience at Weill Cornell Medical College from 2013 to 2017. During her four years in this role, she contributed to various research projects and gained substantial expertise in the field of neuroscience.
Medical Career at Charité
Anja Kahl had multiple roles at Charité. She served as a Physician in the Department of Neurology at the Center for Stroke Research Berlin from 2012 to 2013. Prior to this, she worked as a Physician at the Charité Research Organisation GmbH from 2011 to 2012. She also completed a clinical internship in the Department of Neurology from 2010 to 2011.
Education and Medical Degree
Anja Kahl studied Medicine at Charité University Medicine Berlin, where she achieved her Doctor of Medicine (MD) degree. Her educational journey spanned from 2003 to 2012, totaling nine years of rigorous medical training and education.
Clinical Internships Worldwide
Anja Kahl has completed numerous clinical internships around the world. In 2010, she interned in the Department of Cardiothoracic Surgery at Stellenbosch University for two months and in the Department of General Surgery at the University of Basel for 11 months. She also interned in the Department of Internal Medicine at Brandenburg Hospital for 11 months in 2010. Additionally, she completed internships at King's College London (2009), Saitama Medical University (2008), and Pontificia Universidad Católica del Ecuador (2007), each lasting 11 months.